Published: Jeffrey Cummings

Jeffrey Cummings (Brain Health) co-authored a paper published in Nature on developing the ATX(N) classification, a system for recognizing biomarkers in blood that indicate the presence in the brain of plaques and tangles characteristic of Alzheimer’s disease.  ATX(N) advances allow researchers to diagnose Alzheimer’s disease without imaging or autopsy; the tests may soon become available for clinical use. Cummings is part of the Chambers-Grundy Center for Transformative Neuroscience at UNLV.

People in the News

People | December 3, 2021
An immigrant herself, Aziza Dhalai says she remembers how scary it can be to arrive in a new country.
People | November 30, 2021
Former flight attendant Ben Jantzen on being a nontraditional student and discovering a new career in college.
A woman leans on a cubicle wall
People | November 29, 2021
The Cannon Survey Center's data and operations manager grew up rural – very rural.